US Edition
CureDuchenne Appoints Brenda Wong, MD, as Chief Medical Advisor to Advance Research and Improve Care for Individuals with Duchenne and Becker
- On May 21, 2025, CureDuchenne revealed that Brenda Wong, MD, will assume the role of Chief Medical Advisor starting January 5, 2026.
- This appointment comes as CureDuchenne marks two decades of dedication to advancing research and providing resources aimed at eliminating Duchenne muscular dystrophy, a prevalent and serious muscle-wasting disease.
- Dr. Wong brings over 20 years of pediatric neuromuscular expertise, having led centers at Cincinnati Children’s and University of Massachusetts.
- CureDuchenne’s CEO Debra Miller emphasized that Dr. Wong’s deep care for families, bold leadership, and relentless efforts to improve treatment align closely with the organization’s mission.
- Dr. Wong will guide clinical strategies, collaborate on trials, empower families, and share her expertise at CureDuchenne’s 2025 FUTURES Conference in San Antonio.
14 Articles
14 Articles
Lompoc Record
CureDuchenne Appoints Brenda Wong, MD, as Chief Medical Advisor to Advance Research and Improve Care for Individuals with Duchenne and Becker Muscular Dystrophy
NEWPORT BEACH, Calif., May 21, 2025 /PRNewswire/ -- CureDuchenne, a global nonprofit committed to finding and funding a cure for Duchenne muscular dystrophy, proudly announces the appointment of Brenda Wong, MD, as its new Chief Medical Advisor, effective January 5,…
CureDuchenne Appoints Brenda Wong, MD, as Chief Medical Advisor to Advance Research and Improve Care for Individuals with Duchenne and Becker
Newport Beach, Calif., May 21, 2025 — CureDuchenne, a global nonprofit committed to finding and funding a cure for Duchenne muscular dystrophy, proudly announces the appointment of Brenda Wong, MD, as its new Chief Medical Advisor, effective January 5, 2026. A nationally recognized authority in neuromuscular medicine and clinical research, Dr. Wong has devoted her career to compassionate, patient-centered care for those living with Duchenne and …
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
